The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015

Abdullah J Alsahafi, Allen C Cheng, Abdullah J Alsahafi, Allen C Cheng

Abstract

Objectives: The aim of this study was to review the epidemiology of cases of Middle East respiratory syndrome coronavirus (MERS-CoV) reported in the Kingdom of Saudi Arabia from 2012 when the first MERS-CoV was confirmed up to July 2015.

Methods: MERS-CoV data were obtained from the Saudi Ministry of Health for the period 2012 to July 2015. Descriptive statistics were used to summarize the results regarding the risk factors and mortality of MERS-CoV infection.

Results: In this series, the risk factors and outcomes of 939 cases of MERS-CoV occurring in the last 3 years are described. The majority of the affected patients were aged ≥40 years (n=657; 70%). Of the 657 patients aged ≥40 years, 377 (57.3%) died.

Conclusions: The case-fatality ratio was found to increase significantly with age. It ranged from 12.5% in those aged ≤19 years to 86.2% in those aged ≥80 years. The results confirmed the association between severe MERS-CoV illness and patients with a pre-existing health morbidity. The duration from symptom onset to admission was not statistically associated with the disease outcome.

Keywords: Coronavirus; Coronavirus infections; Epidemiology; Middle East respiratory syndrome coronavirus; Risk factors.

Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Age distribution of MERS-CoV cases reported in the Kingdom of Saudi Arabia during the period 2012 to July 2015, by location of acquisition.
Figure 2
Figure 2
Distribution of MERS-CoV cases in the Kingdom of Saudi Arabia during the period 2012 to July 2015, by month of onset of symptoms.

References

    1. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820.
    1. Leshem E. Severe respiratory illness associated with a novel coronavirus — Saudi Arabia and Qatar, 2012. JAMA. 2012;308(20):2077–2078. [cited 2015 October 27], .
    1. Memish Z.A., Cotten M., Meyer B., Watson S., Asahafi A.J., Al Rabeeah A.A. Human infection with mers coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerging Infectious Disease journal. 2014;20(6):1012–1015.
    1. Al-Tawfiq J.A., Assiri A., Memish Z.A. Middle East respiratory syndrome novel corona (MERS-CoV) infection: epidemiology and outcome update. Saudi Med J. 2013;34:991–994.
    1. Drosten C., Muth D., Corman V.M., Hussain R., Al Masri M., Haj Omar W. An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis. 2015;60:369–377.
    1. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407–416.
    1. World Health Organization. Global Alert and Response. Coronavirus infections, 2015. WHO; 2015. Available at: (accessed October 27, 2015).
    1. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752–761.
    1. Alghamdi I.G., Hussain I.I., Almalki S.S., Alghamdi M.S., Alghamdi M.M., El-Sheemy M.A. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med. 2014;7:417–423.
    1. Memish Z.A., Zumla A.I., Al-Hakeem R.F., Al-Rabeeah A.A., Stephens G.M. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013;368:2487–2494.
    1. Majumder M.S., Kluberg S.A., Mekaru S.R., Brownstein J.S. Mortality risk factors for middle east respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Disease J. 2015;21(11):2088–2090.
    1. Spanakis N., Tsiodras S., Haagmans B.L., Raj V.S., Pontikis K., Koutsoukou A. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents. 2014;44:528–532.
    1. Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13:745–751.
    1. Poissy J., Goffard A., Parmentier-Decrucq E., Favory R., Kauv M., Kipnis E. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol. 2014;61:275–278.
    1. Su S., Wong G., Liu Y., Gao G.F., Li S., Bi Y. MERS in South Korea and China: a potential outbreak threat? The Lancet. 2015;385(9985):2349–2350.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel